Abstract
Cardiovascular disease is the leading cause of death in women over the age of 60. Over the last decade it has become clear that many physiological mechanisms are influenced by female sex hormones. New cardiovascular risk factors and markers are being identified. The changes in cardiovascular risk factors with menopause and hormone replacement therapy are reviewed. Types and routes of hormone replacement therapy and the effect of addition of progestogens are discussed where data are available. Lipids, coagulation, inflammation, endothelin-1 and homocysteine are examined.
Get full access to this article
View all access options for this article.